Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

cancer > cancer > Flashcards

cancer Flashcards

1
Q

most common cancer

A

male: colorectal, lung, prostate
female: breast, colorectal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

neoplasia

A

abnormal mass of tissue, the growth of which exceeds and is uncoordinated with that of normal tissue and persists in the same excessive manner after cessation of the stimuli that evoked the change

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

types of neoplasm

A

uncontrolled cell growth -> high rate of cell growth exceed cell death -> aggressive cancer

decreased rate of cell death -> indolent cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

dysplasia

A

abnormal change in size, shape and/or organisation of cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

metaplasia

A

change in cell type

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

in situ cancer

A

neoplasm is malignant but has no invaded pass the basement membrane

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

invasive cancer

A

spread beyond basement membrane -> invasive and metastatic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

relationship between dysplasia and malignant neoplasia

A

dysplasia -> malignant neoplasia (cancer)

dysplasia is precursor to cancer but not cancer

in dysplasia, once tumour suppressor genes and proto-oncogenes are affected, can lose regulation of cell cycle and become malignant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

benign neoplasia

A

dysregulated growth
- cells highly resemble original cell type and is well circumscribed
- does not become malignant neoplasia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

benign vs malignant neoplasia

A

gross features

  • circumscription
    B: well-circumscribed mass
    M: poorly-circumscribed mass
  • necrosis/haemorrhage
    B: no
    M: yes

microscopic features
- mitotic figures
B: no/few mitotic figures
M: mitotic figures present

  • N/C ratio
    B: normal N/C ratio
    M: high N/C ratio

infiltration
B: no infiltration
M: infiltrative (into surrounding tissue)

genetic features
- DNA content
B: normal
M: increased DNA content (additional chromosomes)

  • karotype
    B: normal
    M: anueploidy, polyploidy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

histological appearance of cancer cells

A
  1. hyperchromasia
  2. pleomorphism (diff shapes and sizes of cancer cells)
  3. high mitotic index
  4. high nuclear: cytoplasmic ratio
  5. clumped chromatin irregularly distributed
  6. enlarged/abnormally shaped/ multiple nucleoli
  7. infiltrative growth (irregular outline)
  8. metastasis
  9. anaplasia (dont resemble tissue of orgin)
  10. poorly formed/leaky blood vessels

Hello peter’s mom nancy can Nicole impress me again lol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

“All oma’s are _______ other than ___(3)___”

“Sarcoma” ?

“Carcinoma”?

“Adenoma”?

“Adenocarcinoma”?

“Teratoma”?

A

“All oma’s are benign other than LYMPHOMA, MELANOMA, GLIOMA ”

“Sarcoma” - arise from connective tissue (mesenchymal)

“Carcinoma” - arise from epithelial tissue/ endothelial lining of organs (ectoderm/endoderm)

“Adenoma”- glandular origin Glandular (what tells you it’s an adenoma, 1)

“Adenocarcinoma” Glandular AND epithelial origins

“Teratoma”- totipotent germ cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

identifying features of carcinoma

A

carcinoma: keratinisation, keratin pearls, bridging, cell shape

adenoma: intracellular mucin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

leiomyo-
papillo-
rhabdomyo-
blastomas

A

Leiomyo- smooth muscle (ie esopahgus, uterus)
Papillo- papillary appearance
Rhabdomyo- striated muscle (skeletal or cardiac)
Blastomas- “blast” cells (progenitor cells)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

mutations causing cancer

A

for cancer, need to have mutation in both TSG and PO

  1. tumour suppressor gene -> loss of function mutation
    - act recessively (need both alleles to be mutated)
    eg FAP, Li Fraumeni Syndrome, BRCA 1/2
  2. proto-oncogene -> gain in function mutation
    - act dominantly
    eg MYC (Burkitt’s Lyphoma), Philadelphia Chromosome, HHV8
  3. mismatch repair genes
    - mutation in MMR genes result in inability to repair mutations in TSG and PO
    eg HNPCC
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

FAP

A

familial adenomatous polyposis
- loss of function mutation in both alleles of tumour suppressor gene (autosomal dominant)
- 100% risk of colon cancer before 50 years old
- cause polyps in colon with varying degrees of dysplasia
- some will develop into cancer since dysplasia -> malignant neoplasia

17
Q

Li Fraumeni Syndrome

A

germline mutation of 1 allele of p53 tumour suppressor gene in all cells
- only need 1 more mutation in the other allele of the p53 gene in any cell to cause cancer
(predisposition to all cancers)

18
Q

BRCA 1/2

A

breast cancer 1/2
- mutation in this tumour suppressor gene increases likelihood of getting breast, ovarian or other types of cancer

19
Q

MYC

A

MYC is the main transcription factor that promotes growth (proto-oncogene)
- gain in function mutation of MYC causes Burkitt’s lymphoma with a starry sky appearance (B cell cancer)
- many B cells with a lot of cell debris that are consumed by macrophages so B cells punctuated by macrophages look like a starry sky

20
Q

Philadelphia Chromosome

A

translocation between chromosome 9 and 22 to form BCR/ABL gene on chromosome 22
- BCR/ABL gene codes for constitutively active receptor tyrosine kinase which upregulates growth and mitosis (even in absence of growth factor)
- cause Chronic Myeloid Leukemia

21
Q

HHV8 (Kaposi’s sarcoma associated virus)

A

proto-oncogene associated with Kaposi’s sarcoma
- herpes virus contains gene that codes for oncoprotein so when transcribed and translated by host cell, it forms more oncoproteins which stimulate the cell to divide uncontrollably

22
Q

HNPCC

A

hereditary non-polyposis colorectal cancer
- caused by germline mutation of 1 MMR gene (recessive allele)

23
Q

FAP vs HNPCC

A

FAP
- mutation in both copies of APC tumour suppressor gene -> have many adenomatous polyps in colon -> 100% risk of cancer
- cancer can arise from anywhere in colon

HNPCC
- 1 mutated allele of MMR gene passed down so need mutation in other allele of MMR gene to increase susceptibility to mutations in TSG and protooncogene causing cancer
- do not have polyps that could turn cancerous
- cancer arises from colon wall spontaneously and directly
- more commonly associated with rught sided colorectal cancer and high possibility of developing other colon cancers

24
Q

epithelial-mesenchymal transition

A

mostly for carcinomas (sarcoma go through analogous process)
1. inactivation of E-cadherin causes loss of contact inhibition and tumour cells gain mobility without undergoing apoptosis
2. basement membrane breached
3. tumour cells transverse the interstitial connective tissue by secreting proteolytic enzymes like matrix metalloproteinases
4. gain access to circulation by penetrating the vascular basement membrane
5. transit through vasculature
6. extravasate from vessel
7. angiogenesis

25
Q

metastasis

A

spread of primary cancers to distal sites

26
Q

primary and secondary lesions

A

primary lesion: at site of origin, may or may not have metastasised (cannot tell by just look at primary lesion)

secondary lesion: at distal site, indicate metastasis and may be singular or multiple
(if tumour cells do not resemble neighbouring cells, likely to have come from distal site indicating metastasis

27
Q

metastasis: patterns of spread

A
  1. hematogenous spread
    - carcinomas
    - spread through veins (thinner and more penetrable walls)
  2. lymphatic spread
    - sarcomas
    - for sarcomas in ECM, tumour cells that lose contact inhibition can be carried by interstitial fluid in connective tissue and drained into lymphatic vessels and lymph nodes
    - interstitial fluid -> lymphatic vessels > lymph nodes -> venous system
  3. spread through body cavities
    - common in ovarian or GIT cancer
    ovarian: cancer cells enter through space between ovary and fallopian tube

GIT: tumour cells in GIT can burst through walls of organs and enter peritoneal cavity

  • tumour can seed across large space and gain access to more body components (bad prognosis)
28
Q

why are some organs more prone to metastasis than others

A
  1. lymph nodes
    - tunour cells from both lympathic spread and hematogenous spread will pass through lymph nodes
  2. lungs, liver and bone
    lungs: metastasis via caval venous system
    - metastases will lodge in first organ it reaches with narrow capillaries
    - in lungs, walls are thinner and narrower so easier for cancer cells to get lodged and squeeze out of capillaries

liver: metastasis by portal venous system
- cancer of organs in GIT (+spleen and pancreas likely to metastise liver first

bone: highly vascularised and tumour cells can spread through blood and bone have favourable microenvironment with a lot of growth factors and nutrients

  1. vertebral column
    - cancers near vertebral column embolise through paravertebral plexus (tight group of blood vessels near spine) and have vertebra metastasis
    2 cancers most likely to spread to vertebral column -> thyroid, prostatic
29
Q

paraneoplastic syndrome

A

system complexes not attributable
- local or distant spread of tumour
- hormonal effects indigenous to tissue of origin

eg cushing’s syndrome in small cell lung carcinoma
hypercalcemia in squamous cell lung carcinoma
myasthenia gravis in thymoma (cancer of thymus)

30
Q

why is grading and staging useful?

A

determines prognosis and therapy options

31
Q

grading

A

how differentiated? (how much the cancer cell resembles the original tissue)
- well differentiated/ moderately differentiated/poorly differentiated (refers to degree of malignancy)
- based on arrangement of cell and cellular features like the

32
Q

staging

A

How widespread?

TNM criteria: tumour, node, metastasis
tumour -> extent of invasion at primary site
node -> number of lymph nodes involved
metastasis -> present of metastasis at distant sites (M0: no metastasis and M1: presence of metastasis

33
Q

tumour markers

A

used as a screening methods for the detection of cancer and monitoring the amount of of residual tumour or tumour recurrence post therapy

eg
hormone -> Human chorionic gonadotropin
oncofetal antigens -> alpha-fetoprotein (AFP), carcinoembryonic antigen (CEA)
specific protein -> prostate specific antigen (PSA)
glycoproteins-> CA-125 for ovarian cancer

34
Q

local effects of tumour

A

palpable mass
pain
haemorrhage and ulceration
obstruction
neuropathies

35
Q

describe the gross appearance of a malignant tumour

A

Is POORLY CIRCUMSCRIBED,
NONENCAPSULATED
With a POORLY DEFINED CLEAVAGE PLANE
With SUBSTANTIAL INFILTRATION

cancer (3 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions